This conference has ended. This page will be updated when information on next year's conference becomes available.
December 5, 2020 (Saturday)
Virtual Education Day - A Live Internet Event
4.75 AMA PRA Category 1 CreditsTM
This conference is targeted for Physicians, Basic Researchers, Mid-Level Practitioners, Advocates, Caregivers, Nurses, and Pharmacists.
- Conference Brochure
- Conference Speakers/Committee
- Conference Agenda
- Abstracts Information
Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts and so forth.
Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Email: email@example.com. All responses will be forwarded to the Program Chair for consideration.
Inflammatory breast cancer (IBC) is a highly aggressive breast cancer, with a very poor prognosis relative to other breast cancers due to its strong potential to metastasize, relapse, and possibly result in patient death. There have been multiple attempts to develop efficacious targeted therapy for this disease. Unfortunately, the federal government (FDA) has not approved any IBC-specific drugs or diagnostic tools yet. Therefore, there remains an urgent need to understand mechanistically how to induce a therapeutic effect that can prolong the survival of patients with IBC. This two-day meeting is targeted for clinical investigators, practicing physicians, basic researchers, patient advocates and institutions aiming to pioneer IBC clinics in their geographic regions, to enhance their knowledge and to facilitate collaboration to accelerate clinical therapy and research trial development, beneficial for patients with IBC. We expect new ideas and collaborations from this meeting to lead to improvement of disease outcome, such as survival or tumor response, over the next 3 years.
- Review IBC and metastatic breast cancer standard of care diagnosis and treatment including the rationale for differences from other breast cancers;
- Discuss ongoing clinical trials of IBC and metastatic breast cancer from both the biology perspective and operations to discuss expansion of collaboration in the US;
- Incorporate new concepts in the biology and latest developments of the ongoing translational research related to IBC and metastatic breast cancer;
- Discuss how we can translate our basic research findings as clinical research or into the clinic.
- Lecture – Live Online
- Panel Discussion
- Question and Answer Sessions
- Poster Session/Presentations
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas MD Anderson Cancer Center designates this live internet course for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Certificates and Attendance Verification Certificates
Certificates awarding AMA PRA Category 1 Credit™ or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME verification form. Upon request, a record of attendance (certificate) will be provided to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.
Physician Payments Sunshine Act
MD Anderson complies with the Physician Payments Sunshine Act as part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfer of value to any covered recipient under the ACA.
The Education Day will be held Saturday, December 5, 2020. Opening remarks will begin at 8:30am and the Education Day will close with a Poster Presentation Session that evening.
The virtual conference registration includes access to online education materials.
The deadline for advanced registration is Friday, November 27, 2020.
Registration Fees - A Free IBC Education Event
- Physicians (MD, PhDs)
- Healthcare Professionals (Nurses/PAs, etc.)
- Patients, Caregivers, Advocates
Help us raise funds and awareness of Inflammatory Breast Cancer by joining our Boot Walk IBC Wranglers team. Join team IBC Wranglers, walk 1.2 miles anywhere you are, any day and at any time.
- Registration is free. http://mdacc.convio.net/goto/IBCWranglers
- Click on ‘JOIN THIS TEAM’ and go through the registration steps.
If you would like to donate (TAX deductible) to team IBC Wranglers:
- If you are sending a check: PAY TO MD Anderson Cancer Center, Memo: BWH20 IBC Wranglers, and mail the check to MD Anderson Boot Walk, P.O. Box, 4470, Houston, TX 77210
Registration On-line (Below): you may experience intermittent problems with using the Google or FireFox Brower’s, we recommend that you use Internet Explorer Browser when registering on-line.
There are two other ways to register:
Continuing Professional Education, Unit 1781
The University of Texas MD Anderson Cancer Center
P.O. Box 301407
Houston, TX 77230-1707
Email to: firstname.lastname@example.org (Printable Form)
A receipt and confirmation letter will be sent to you within ten working days of receipt of your fee.
Photographing, audio taping and videotaping are prohibited.